KERYX BIOPHARMACEUTICALS (KERX) 3.92 $0.07 (1.82%) 07:45AM (15 mins delay)

KERX

$3.92 $0.07 (1.82%)

You need to upgrade your Flash Player

Today

10y

Last:	$3.92	High:	$3.95
Prev Close:	$3.85	Low:	$3.85
Open:	$3.91	Mkt Cap:	$227M
Change:	$0.07 ( 1.82% )	52Wk High:	$6.67
Vol:	428,870	52Wk Low:	$1.33
Avg Volume:	676,785	Shares:	58.92B
EPS:	-0.25	PE Ratio:	-

Start trading KERX with real money!

Company Description

A biopharmaceutical company focused on the acquisition and development of novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

	fproano	Apr 12 8:29 PM
	Thank you to those who told me about this over a year ago, I got in at 14 cents a share, I have held and will hold, thanks again, luv u - Comment

	Victor Lucas	Mar 21 12:27 PM
	KERX, like BCRX, is a stock that requires a patient mind. - KERX Comment

	Shahid Nisar	Oct 15 4:45 PM
	buying some today - KERX Comment

	Tim Graffius	Sep 17 3:25 AM
	let it sit for bout 8 months and gained 750%! - KERX Comment

	Dee C	Jul 23 10:33 AM
	kerx is beaking out! - KERX Comment

KERYX BIOPHARMACEUTICALS (KERX) Stock News & Analysis

LifeSci Advisors Initiates Coverage on Keryx Biopharmaceuticals	08/02/2010
LifeSci Advisors Initiates Coverage on Keryx Biopharmaceuticals	08/02/2010
Keryx Biopharm: Real Moves Yet to Materialize	07/15/2010
Today's Big Gainers: AKS, PVX, KERX, EGI	07/14/2010
Keryx Biopharmaceuticals Receives FDA Orphan Approval For Treatment of Neuroblastoma	07/14/2010
Biotech Stock Mailbag Readers' Portfolio: Update	06/15/2010	TheStreet
Curtain Closes on ASCO: 2010's Few Winners	06/09/2010
Biotech Trades for the 2010 ASCO Conference	05/13/2010
Cramer's Lightning Round - JDSU: Just Don't Sell Us (5/10/10)	05/11/2010
Mad Money Lightning Round: HUN Has Gone From Good To Better To Great, Says Jim (HUN, KERX, PALM, AMZN, AAPL, ASH, WIN, SNV, JDSU)	05/11/2010
AEterna Zentaris: Uncovering Next Dominant Cancer Company	05/06/2010
Charts of the Day - Harry Boxer, TheTechTrader.com	05/04/2010
Infinity Pharmaceuticals: A Promising, Underappreciated Cancer Drug Maker	04/14/2010
Monday Midday Sector Leaders: Title Insurance, Major Drug Manufacturers	04/12/2010
Keryx Biopharmaceuticals: The Trend Continues Higher (KERX)	04/12/2010